Neuro-Oncology
Astrocytoma IDH mutant, WHO grade 2
Mar. 01, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Enhanced T1-weighted MRI (TR 750/TE 32) scans of patient shown in Brainstem glioma (7), (9), and (12), demonstrating a partial response (50% to 90% reduction of tumor volume) of the pontine anaplastic astrocytoma to chemotherapy with intraarterial carboplatin and intravenous etoposide. (A and C) Prechemotherapy baseline scans of enhancing brainstem lesion. (B and D) Same images as A and C, following 2 cycles of chemotherapy, showing significant reduction in tumor volume and enhancement. (Contributed by Dr. Herbert Newton.)